Andjela Kusic-Pajic, MD
Rare Disease / Clinical Research
Actelion
QC-verified· March 2026 PI on 2 trials 1 publication
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Clinical trials (2)
Verify independently
Other specialists for Drug- or toxin-induced pulmonary arterial hypertension
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Eric Austin, MDVanderbilt Medical Center
- Ekkehard Grünig, MDThoraxclinic at the University of Heidelberg
- Nicholas S Hill, MDTufts Medical Center
- Sudarshan Rajagopal, MD, PhD, M.DDuke Health SystemNC
- Richard ArandaGossamer Bio Inc.
- Horst Olschewski, MDMedical University of Graz
- Swee Lay Thein, M.D., MDNational Heart, Lung, and Blood Institute (NHLBI)MD
- Mamta Fuloria, MD, MDMontefiore Medical CenterNJ
See all specialists for Drug- or toxin-induced pulmonary arterial hypertension →